Fesoterodine Fumarate is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Alembic Pharmaceuticals Inc.. The primary component is Fesoterodine Fumarate.
Product ID | 62332-176_d347263f-9458-4986-be65-e626f490bb3b |
NDC | 62332-176 |
Product Type | Human Prescription Drug |
Proprietary Name | Fesoterodine Fumarate |
Generic Name | Fesoterodine Fumarate |
Dosage Form | Tablet, Extended Release |
Route of Administration | ORAL |
Marketing Start Date | 2023-01-06 |
Marketing Category | ANDA / |
Application Number | ANDA204973 |
Labeler Name | Alembic Pharmaceuticals Inc. |
Substance Name | FESOTERODINE FUMARATE |
Active Ingredient Strength | 8 mg/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2024-12-31 |
Marketing Start Date | 2023-01-06 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
43598-247 | Fesoterodine fumarate | Fesoterodine fumarate |
43598-248 | Fesoterodine fumarate | Fesoterodine fumarate |
51407-661 | Fesoterodine fumarate | Fesoterodine fumarate |
51407-662 | Fesoterodine fumarate | Fesoterodine fumarate |
62332-175 | Fesoterodine Fumarate | Fesoterodine Fumarate |
62332-176 | Fesoterodine Fumarate | Fesoterodine Fumarate |
62559-376 | Fesoterodine Fumarate | Fesoterodine Fumarate |
65162-369 | Fesoterodine Fumarate | Fesoterodine Fumarate |
65162-370 | Fesoterodine Fumarate | Fesoterodine Fumarate |
65862-766 | FESOTERODINE FUMARATE | FESOTERODINE FUMARATE |
68382-479 | fesoterodine fumarate | fesoterodine fumarate |
68382-480 | fesoterodine fumarate | fesoterodine fumarate |
70771-1168 | fesoterodine fumarate | fesoterodine fumarate |
70771-1169 | fesoterodine fumarate | fesoterodine fumarate |
0069-0242 | Toviaz | fesoterodine fumarate |
0069-0244 | Toviaz | fesoterodine fumarate |
55154-2737 | Toviaz | fesoterodine fumarate |
55154-2738 | Toviaz | fesoterodine fumarate |
63539-183 | Toviaz | fesoterodine fumarate |
63539-242 | Toviaz | fesoterodine fumarate |